Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Isotechnika Pharma Inc IPHAF

GREY:IPHAF - Post Discussion

Isotechnika Pharma Inc > GOLLY,GEE JOLLY, MUTTON-CHOPS, ROBIN!!!
View:
Post by ISAloser247 on Nov 07, 2012 11:56am

GOLLY,GEE JOLLY, MUTTON-CHOPS, ROBIN!!!

ISA share price is back down on EARTH!!  after soaring 66 % , with close to 2 million shares being exchanged, Santa's sack seems to have been emptied!  From hundreds of thousands being asked for,  it is DOWN to a  few  measly 5, 000.  HOW, BOY WONDER, COULD SUCH POSITIVE NEWS not sustain momentum?  THIS WAS THE YEAR!!!!  2012  WAS TO HAVE BROUGHT MANY VALUE-ADDED ANNOUNCEMENTS FOR STAKEHOLERS!!!   THE 'DEAR SHAREHOLDER' LETTER HAD SAID SO!!!!  THAT LETTER, ROBIN , WAS SO TRUTHFUL , HONEST ,  AND FORWARD-LOOKING,  IT WAS , AS IF < IT HAD COME FROM SOMEONE PURE , FROM ON HIGH.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities